Skip to main content
Erschienen in: World Journal of Urology 5/2013

01.10.2013 | Topic Paper

Is gender becoming relevant in uro-oncological research? A bibliographical analysis

verfasst von: Frank Kunath, Bastian Keck, Simone Bertz, Sabine Brookman-May, Matthias May, Daniel Vergho, Arndt Hartmann, Hubertus Riedmiller, Bernd Wullich, Maximilian Burger

Erschienen in: World Journal of Urology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Gender differences are increasingly recognized as important in numerous diseases and found to be relevant in various cancer entities. While a larger number of manuscripts on gender effects in gastro-intestinal and pulmonary neoplasms have been published, urological malignancies involving men and women alike seem less studied in this regard. The present analysis aimed at describing the role of gender effects in general oncological and uro-oncological research and is the first such bibliometrical analysis.

Methods

The electronic database MEDLINE was searched for relevant medical subject headings from January 1991 to December 2011. Publication types, publishing journal and impact factors were identified. Trends were assessed by linear regression.

Results

The numbers of annual publications on all major tumour entities and on urological malignancies increased similarly. While the portion of publications on gender effects was below 1 % for each tumour entity, the annual increase of novel publications on gender effects was significant in most and prominent in pulmonary (1.87, 95 % CI 1.11–2.63; <0.0001) and colorectal neoplasms (2.16, 95 % CI 1.49–2.82; <0.0001). While the annual increase of novel publications on gender effects was significant in bladder cancer (0.33, 95 % CI 0.11–0.54; 0.005), it failed level of significance in renal cell cancer (0.25, 95 % CI −0.19–0.24; 0.82).

Conclusion

While the overall role of gender effect seems small in general oncological research, it is increasing steadily. In uro-oncological research, such trend is also visible in bladder but not in renal cell cancer. Respective awareness on importance of gender effects should be raised.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Alex L, Fjellman Wiklund A, Lundman B, Christianson M, Hammarström A (2012) Beyond a dichotomous view of the concepts of ‘sex’ and ‘gender’ focus group discussions among gender researchers at a medical faculty. PLoS One 7(11):e50275PubMedCrossRef Alex L, Fjellman Wiklund A, Lundman B, Christianson M, Hammarström A (2012) Beyond a dichotomous view of the concepts of ‘sex’ and ‘gender’ focus group discussions among gender researchers at a medical faculty. PLoS One 7(11):e50275PubMedCrossRef
3.
Zurück zum Zitat Verdonk P, Klinge I (2012) Mainstreaming sex and gender analysis in public health genomics. Gend Med 9(6):402–410PubMedCrossRef Verdonk P, Klinge I (2012) Mainstreaming sex and gender analysis in public health genomics. Gend Med 9(6):402–410PubMedCrossRef
4.
Zurück zum Zitat González-Ortega I, Echeburúa E, Corral P, Polo-López R, Alberich S (2012) Predictors of pathological gambling severity taking gender differences into account. Eur Addict Res 19(3):146–154PubMedCrossRef González-Ortega I, Echeburúa E, Corral P, Polo-López R, Alberich S (2012) Predictors of pathological gambling severity taking gender differences into account. Eur Addict Res 19(3):146–154PubMedCrossRef
5.
6.
Zurück zum Zitat van Rijsingen IA, Nannenberg EA, Arbustini E, Elliott PM, Mogensen J, Ast JF, van der Kooi AJ, van Tintelen JP, van den Berg MP, Grasso M, Serio A, Jenkins S, Rowland C, Richard P, Wilde AA, Perrot A, Pankuweit S, Zwinderman AH, Charron P, Christiaans I, Pinto YM (2012) Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers. Eur J Heart Fail 15(4):376–384PubMedCrossRef van Rijsingen IA, Nannenberg EA, Arbustini E, Elliott PM, Mogensen J, Ast JF, van der Kooi AJ, van Tintelen JP, van den Berg MP, Grasso M, Serio A, Jenkins S, Rowland C, Richard P, Wilde AA, Perrot A, Pankuweit S, Zwinderman AH, Charron P, Christiaans I, Pinto YM (2012) Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers. Eur J Heart Fail 15(4):376–384PubMedCrossRef
7.
Zurück zum Zitat Newman JD, Davidson KW, Ye S, Shaffer JA, Shimbo D, Muntner P (2012) Gender differences in calls to 9–1-1 during an acute coronary syndrome. Am J Cardiol 111(1):58–62PubMedCrossRef Newman JD, Davidson KW, Ye S, Shaffer JA, Shimbo D, Muntner P (2012) Gender differences in calls to 9–1-1 during an acute coronary syndrome. Am J Cardiol 111(1):58–62PubMedCrossRef
8.
Zurück zum Zitat Hofer-Dückelmann C (2012) Gender and polypharmacotherapy in the elderly: a clinical challenge. Handb Exp Pharmacol 214:169–182PubMedCrossRef Hofer-Dückelmann C (2012) Gender and polypharmacotherapy in the elderly: a clinical challenge. Handb Exp Pharmacol 214:169–182PubMedCrossRef
9.
Zurück zum Zitat Morgan CP, Bale TL (2012) Sex differences in microRNA regulation of gene expression: no smoke, just miRs. Biol Sex Differ 3(1):22PubMedCrossRef Morgan CP, Bale TL (2012) Sex differences in microRNA regulation of gene expression: no smoke, just miRs. Biol Sex Differ 3(1):22PubMedCrossRef
10.
Zurück zum Zitat Kiyohara C, Ohno Y (2010) Sex differences in lung cancer susceptibility: a review. Gend Med 7(5):381–401PubMedCrossRef Kiyohara C, Ohno Y (2010) Sex differences in lung cancer susceptibility: a review. Gend Med 7(5):381–401PubMedCrossRef
11.
Zurück zum Zitat Brändstedt J, Wangefjord S, Nodin B, Gaber A, Manjer J, Jirström K (2012) Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study. Biol Sex Differ 3(1):23PubMedCrossRef Brändstedt J, Wangefjord S, Nodin B, Gaber A, Manjer J, Jirström K (2012) Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study. Biol Sex Differ 3(1):23PubMedCrossRef
12.
Zurück zum Zitat Chen CJ, Sung WW, Lin YM, Chen MK, Lee CH, Lee H, Yeh KT, Ko JL (2012) Gender difference in the prognostic role of interleukin 6 in oral squamous cell carcinoma. PLoS One 7(11):e50104PubMedCrossRef Chen CJ, Sung WW, Lin YM, Chen MK, Lee CH, Lee H, Yeh KT, Ko JL (2012) Gender difference in the prognostic role of interleukin 6 in oral squamous cell carcinoma. PLoS One 7(11):e50104PubMedCrossRef
13.
Zurück zum Zitat Mandal R, Bolt DM, Shah BK (2012) Disparities in chronic myeloid leukemia survival by age, gender, and ethnicity in pre- and post-imatinib eras in the US. Acta Oncol [Epub ahead of print] Mandal R, Bolt DM, Shah BK (2012) Disparities in chronic myeloid leukemia survival by age, gender, and ethnicity in pre- and post-imatinib eras in the US. Acta Oncol [Epub ahead of print]
14.
Zurück zum Zitat Jacobs-Lawson JM, Schumacher MM, Hughes T, Arnold S (2010) Gender differences in psychosocial responses to lung cancer. Gend Med 7(2):137–148PubMedCrossRef Jacobs-Lawson JM, Schumacher MM, Hughes T, Arnold S (2010) Gender differences in psychosocial responses to lung cancer. Gend Med 7(2):137–148PubMedCrossRef
15.
Zurück zum Zitat Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, Breinl E, Merseburger AS, Shariat SF (2011) Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 29(4):457–463PubMedCrossRef Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, Breinl E, Merseburger AS, Shariat SF (2011) Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 29(4):457–463PubMedCrossRef
16.
Zurück zum Zitat Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y (2012) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63(2):234–241PubMedCrossRef Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y (2012) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63(2):234–241PubMedCrossRef
17.
Zurück zum Zitat Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306(7): 737–745 (Erratum in: JAMA 2011 Nov 23;306(20): 2220) Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306(7): 737–745 (Erratum in: JAMA 2011 Nov 23;306(20): 2220)
18.
Zurück zum Zitat McCauley LR, Beckham CJ, Hunter TB, Nguyen MM (2011) Gender and renal cancer: do variations in clinical presentation and imaging patterns explain observed differences between males and females? Urology 2010(76):536 McCauley LR, Beckham CJ, Hunter TB, Nguyen MM (2011) Gender and renal cancer: do variations in clinical presentation and imaging patterns explain observed differences between males and females? Urology 2010(76):536
19.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer, Lyon, France. GLOBOCAN 2008 v1.2. Available from: http://globocan.iarc.fr, Accessed on 12 Aug 2012 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer, Lyon, France. GLOBOCAN 2008 v1.2. Available from: http://​globocan.​iarc.​fr, Accessed on 12 Aug 2012
20.
Zurück zum Zitat Hew MN, Zonneveld R, Kümmerlin IP, Opondo D, de la Rosette JJ, Laguna MP (2012) Age and gender related differences in renal cell carcinoma in a European cohort. J Urol 188(1):33–38PubMedCrossRef Hew MN, Zonneveld R, Kümmerlin IP, Opondo D, de la Rosette JJ, Laguna MP (2012) Age and gender related differences in renal cell carcinoma in a European cohort. J Urol 188(1):33–38PubMedCrossRef
21.
Zurück zum Zitat Kluth LA, Fajkovic H, Xylinas E, Crivelli JJ, Passoni N, Rouprêt M, Becker A, Comploj E, Pycha A, Holmang S, Gupta A, Lotan Y, Karakiewicz PI, Gontero P, Chun FK, Fisch M, Scherr DS, Shariat SF (2012) Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder. World J Urol [Epub ahead of print] Kluth LA, Fajkovic H, Xylinas E, Crivelli JJ, Passoni N, Rouprêt M, Becker A, Comploj E, Pycha A, Holmang S, Gupta A, Lotan Y, Karakiewicz PI, Gontero P, Chun FK, Fisch M, Scherr DS, Shariat SF (2012) Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder. World J Urol [Epub ahead of print]
22.
Zurück zum Zitat Otto W, Denzinger S, Wieland WF, Hartmann A (2012) First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival. World J Urol 30(6):875–877PubMedCrossRef Otto W, Denzinger S, Wieland WF, Hartmann A (2012) First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival. World J Urol 30(6):875–877PubMedCrossRef
23.
Zurück zum Zitat Faba OR, Palou J, Breda A, Villavicencio H (2012) High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment. World J Urol 30(6):833–840PubMedCrossRef Faba OR, Palou J, Breda A, Villavicencio H (2012) High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment. World J Urol 30(6):833–840PubMedCrossRef
24.
Zurück zum Zitat Keck B, Ott OJ, Häberle L, Kunath F, Weiss C, Rödel C, Sauer R, Fietkau R, Wullich B, Krause FS (2012) Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy. World J Urol [Epub ahead of print] Keck B, Ott OJ, Häberle L, Kunath F, Weiss C, Rödel C, Sauer R, Fietkau R, Wullich B, Krause FS (2012) Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy. World J Urol [Epub ahead of print]
25.
Zurück zum Zitat May M, Stief C, Brookman-May S, Otto W, Gilfrich C, Roigas J, Zacharias M, Wieland WF, Fritsche HM, Hofstädter F, Burger M (2012) Gender-dependent cancer-specific survival following radical cystectomy. World J Urol 30(5):707–713PubMedCrossRef May M, Stief C, Brookman-May S, Otto W, Gilfrich C, Roigas J, Zacharias M, Wieland WF, Fritsche HM, Hofstädter F, Burger M (2012) Gender-dependent cancer-specific survival following radical cystectomy. World J Urol 30(5):707–713PubMedCrossRef
26.
Zurück zum Zitat Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P,Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M (2012) Analysis of gender differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2,500 patients with urothelial carcinoma of the bladder. Gend Med 9(6):481–489 Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P,Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M (2012) Analysis of gender differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2,500 patients with urothelial carcinoma of the bladder. Gend Med 9(6):481–489
27.
Zurück zum Zitat Jentzmik F, Schrader AJ, de Petriconi R, Hefty R, Mueller J, Doetterl J, Eickhoff A, Schrader M (2012) The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome. World J Urol 30(6):733–739PubMedCrossRef Jentzmik F, Schrader AJ, de Petriconi R, Hefty R, Mueller J, Doetterl J, Eickhoff A, Schrader M (2012) The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome. World J Urol 30(6):733–739PubMedCrossRef
28.
Zurück zum Zitat Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Tritschler S, Baba S, Matsushita K, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Otto W, Karakiewicz PI, Ficarra V, Novara G (2011) Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol 29(4):481–486PubMedCrossRef Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Tritschler S, Baba S, Matsushita K, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Otto W, Karakiewicz PI, Ficarra V, Novara G (2011) Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol 29(4):481–486PubMedCrossRef
29.
Zurück zum Zitat Lee S, Jeon HG, Kwak C, Kim HH, Byun SS, Lee SE, Lee E (2012) Gender-specific clinicopathological features and survival in patients with renal cell carcinoma (RCC). BJU Int 110(2 Pt 2):E28–E33PubMedCrossRef Lee S, Jeon HG, Kwak C, Kim HH, Byun SS, Lee SE, Lee E (2012) Gender-specific clinicopathological features and survival in patients with renal cell carcinoma (RCC). BJU Int 110(2 Pt 2):E28–E33PubMedCrossRef
30.
Zurück zum Zitat Kates M, Whalen MJ, Badalato GM, McKiernan JM (2012) The effect of race and gender on the surgical management of the small renal mass. Urol Oncol (Epub ahead of print) Kates M, Whalen MJ, Badalato GM, McKiernan JM (2012) The effect of race and gender on the surgical management of the small renal mass. Urol Oncol (Epub ahead of print)
31.
Zurück zum Zitat Brookman-May S, May M, Ficarra V, Kainz MC, Kampel-Kettner K, Kohlschreiber S, Wenzl V, Schneider M, Burger M, Wieland WF, Otto W, Tilki D, Gilfrich C, Hohenfellner M, Pahernik S, Chromecki TF, Stief C, Zigeuner R; Members of the CORONA (Collaborative Research On Renal Neoplasms Association) Project (2012) Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series. World J Urol (Epub ahead of print) Brookman-May S, May M, Ficarra V, Kainz MC, Kampel-Kettner K, Kohlschreiber S, Wenzl V, Schneider M, Burger M, Wieland WF, Otto W, Tilki D, Gilfrich C, Hohenfellner M, Pahernik S, Chromecki TF, Stief C, Zigeuner R; Members of the CORONA (Collaborative Research On Renal Neoplasms Association) Project (2012) Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series. World J Urol (Epub ahead of print)
Metadaten
Titel
Is gender becoming relevant in uro-oncological research? A bibliographical analysis
verfasst von
Frank Kunath
Bastian Keck
Simone Bertz
Sabine Brookman-May
Matthias May
Daniel Vergho
Arndt Hartmann
Hubertus Riedmiller
Bernd Wullich
Maximilian Burger
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 5/2013
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-013-1069-4

Weitere Artikel der Ausgabe 5/2013

World Journal of Urology 5/2013 Zur Ausgabe

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Fehlerkultur in der Medizin – Offenheit zählt!

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.